Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 14, 2021

Total Value ($000): $237,245 (100.0% shares, 0.0% debt)

Holdings (21)

INSM INSMED INC 13.8%

Value ($000) $32,759 Shares 961,797 Est. Cost $20.81 Unrealized +83.7%

— ZOGENIX INC 11.6%

Value ($000) $27,431 Shares 1,405,259 Est. Cost $31.22 Unrealized —

IOVA IOVANCE BIOTHERAPEUTICS INC 7.6%

Value ($000) $17,916 Shares 565,890 Est. Cost $24.87 Unrealized +66.7%

— ALLAKOS INC 7.1%

Value ($000) $16,949 Shares 147,662 Est. Cost $81.12 Unrealized —

AXSM AXSOME THERAPEUTICS INC 6.0%

Value ($000) $14,245 Shares 251,598 Est. Cost $79.55 Unrealized -11.6%

— TRILLIUM THERAPEUTICS INC 6.0%

Value ($000) $14,211 Shares 1,323,181 Est. Cost $4.53 Unrealized —

ARGX ARGENX SE 6.0%

Value ($000) $14,169 Shares 51,450 Est. Cost $163.87 Unrealized —

— INSTIL BIO INC 5.8%

Value ($000) $13,794 Shares 550,000 Est. Cost $25.08 Unrealized —

COGT COGENT BIOSCIENCES INC 5.8%

Value ($000) $13,688 Shares 1,558,975 Est. Cost $10.99 Unrealized -12.4%

— MIRATI THERAPEUTICS INC 4.9%

Value ($000) $11,614 Shares 67,800 Est. Cost $186.77 Unrealized —

ACAD ACADIA PHARMACEUTICALS INC 4.7%

Value ($000) $11,154 Shares 432,317 Est. Cost $43.17 Unrealized +2.0%

— AMARIN CORP PLC 4.2%

Value ($000) $9,987 Shares 1,608,237 Est. Cost $14.24 Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 3.6%

Value ($000) $8,441 Shares 171,147 Est. Cost $60.17 Unrealized -17.1%

FOLD AMICUS THERAPEUTICS INC 3.3%

Value ($000) $7,795 Shares 788,980 Est. Cost $9.80 Unrealized +58.0%

— SERES THERAPEUTICS INC 3.1%

Value ($000) $7,269 Shares 353,016 Est. Cost $23.44 Unrealized —

— GLOBAL BLOOD THERAPEUTICS IN 3.0%

Value ($000) $7,131 Shares 175,000 Est. Cost $43.31 Unrealized —

KROS KEROS THERAPEUTICS INC 2.8%

Value ($000) $6,729 Shares 109,333 Est. Cost $63.36 Unrealized 0.0%

— VERONA PHARMA PLC 0.3%

Value ($000) $702 Shares 83,944 Est. Cost $6.24 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 0.2%

Value ($000) $581 Shares 35,092 Est. Cost $18.72 Unrealized 0.0%

— THERAPEUTICS ACQUISITION COR 0.2%

Value ($000) $526 Shares 50,000 Est. Cost $10.52 Unrealized —

— CATABASIS PHARMACEUTICALS IN 0.1%

Value ($000) $154 Shares 53,166 Est. Cost $2.90 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
INSM	INSMED INC	961,797	$32,759	13.8%	$20.81	+83.7%	COM PAR $.01	457669307
—	ZOGENIX INC	1,405,259	$27,431	11.6%	$31.22	—	COM NEW	98978L204
IOVA	IOVANCE BIOTHERAPEUTICS INC	565,890	$17,916	7.6%	$24.87	+66.7%	COM	462260100
—	ALLAKOS INC	147,662	$16,949	7.1%	$81.12	—	COM	01671P100
AXSM	AXSOME THERAPEUTICS INC	251,598	$14,245	6.0%	$79.55	-11.6%	COM	05464T104
—	TRILLIUM THERAPEUTICS INC	1,323,181	$14,211	6.0%	$4.53	—	COM NEW	89620X506
ARGX	ARGENX SE	51,450	$14,169	6.0%	$163.87	—	SPONSORED ADR	04016X101
—	INSTIL BIO INC	550,000	$13,794	5.8%	$25.08	—	COM	45783C101
COGT	COGENT BIOSCIENCES INC	1,558,975	$13,688	5.8%	$10.99	-12.4%	COM	19240Q201
—	MIRATI THERAPEUTICS INC	67,800	$11,614	4.9%	$186.77	—	COM	60468T105
ACAD	ACADIA PHARMACEUTICALS INC	432,317	$11,154	4.7%	$43.17	+2.0%	COM	004225108
—	AMARIN CORP PLC	1,608,237	$9,987	4.2%	$14.24	—	SPONS ADR NEW	023111206
ENTA	ENANTA PHARMACEUTICALS INC	171,147	$8,441	3.6%	$60.17	-17.1%	COM	29251M106
FOLD	AMICUS THERAPEUTICS INC	788,980	$7,795	3.3%	$9.80	+58.0%	COM	03152W109
—	SERES THERAPEUTICS INC	353,016	$7,269	3.1%	$23.44	—	COM	81750R102
—	GLOBAL BLOOD THERAPEUTICS IN	175,000	$7,131	3.0%	$43.31	—	COM	37890U108
KROS	KEROS THERAPEUTICS INC	109,333	$6,729	2.8%	$63.36	0.0%	COM	492327101
—	VERONA PHARMA PLC	83,944	$702	0.3%	$6.24	—	SPONSORED ADS	925050106
VRDN	VIRIDIAN THERAPEUTICS INC	35,092	$581	0.2%	$18.72	0.0%	COM	92790C104
—	THERAPEUTICS ACQUISITION COR	50,000	$526	0.2%	$10.52	—	COM CL A	88339T103
—	CATABASIS PHARMACEUTICALS IN	53,166	$154	0.1%	$2.90	—	COM NEW	14875P206